New cause identified for necrotic enteritis in chicken

Researchers from Monash University and CSIRO Livestock Industries have demonstrated for the first time that alpha-toxin protein, long thought to be required for necrotic enteritis to develop, is not the main cause of the chicken disease.

The study, published February 8 in the open-access journal PLoS Pathogens, provides insight into one of the world's most common and financially crippling poultry diseases.

“It's caused by Clostridium perfringens, a bacterium found in soil, litter, dust and in small quantities in the intestines of healthy chickens,” said co-author Anthony Keyburn, “The bacterium only causes disease when it proliferates to high numbers, producing extracellular toxins that attack the bird's intestines, causing lesions.” .

Poultry producers use antibiotics to treat and prevent the disease, which, when triggered, can cause mortality rates of up to 50 per cent. Necrotic enteritis costs the world's poultry industries an estimated US$2 billion every year.

The disease was first described in 1961 and alpha-toxin was implicated as the major causative factor, although definitive proof has never been reported. As a result, for the last 30 years all vaccine development work has been based on the assumption that alpha-toxin was the key.

Mr Keyburn said the research team began to question the involvement of alpha-toxin when a survey showed that local disease-causing bacterial strains produced low levels of this toxin.

“We tested the importance of alpha-toxin by genetically altering the bacterium so it no longer produced any of the protein,” he said. “Despite the toxin's absence, our bacterial isolates still caused disease in chickens. This demonstrates that the development of necrotic enteritis in chickens is not dependent on C. perfringens producing a functional alpha-toxin.”

This finding led the team to expand their search for the real cause of necrotic enteritis, finding a novel toxin – NetB – that is involved in the disease-causing potential of a high proportion of virulent C. perfringens strains.

The authors are now investigating NetB and other proteins produced by C. perfringens, with the aim of developing effective vaccines against the disease.

“Around the world, poultry producers are waiting for vaccines against necrotic enteritis,” said co-author Rob Moore. “Thanks to Anthony's discoveries, scientists should now be able to develop the vaccines within a couple of years.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Huntington’s disease symptoms reduced by new peptide-polymer therapy